Seeking Alpha

Invivyd Announces PEMGARDA™ (pemivibart) Demonstrated 84% Relative Risk Reduction in Symptomatic COVID-19 Compared to Placebo in an Exploratory Analysis from Ongoing CANOPY ...

In all-comer cohort of immunocompetent individuals at risk of contracting symptomatic COVID-19 in their everyday social interactions, participants receiving pemivibart experienced a 1.9% rate of ...
Science Daily

Study finds statins reduce the relative risk of cardiovascular diseases by over 20% in adults aged 75+ with high cholesterol

Researchers provided comprehensive evidence of the benefits of statin use in elderly patients, addressing longstanding uncertainties. The robust evidence demonstrated that continuous statin therapy ...
Hosted on MSN

Statins and Cholesterol Control: How do doctors assess the effectiveness of statin drugs?

Statins Relative Risk Reduction: Statin medications are prescribed to reduce the risk of heart disease and heart attack. However, their benefits vary from person to person. Let us explain them.
Medscape

In Global Trial, PCSK9 Inhibitor Provides Major Protection Against First CV Event

NEW ORLEANS — The first global randomized trial of the PCSK9 inhibitor evolocumab for the prevention of a primary major adverse cardiovascular event (MACE) found a relative reduction in risk similar ...
ascopubs.org

Using the Cell-Cycle Risk Score to Predict the Benefit of Androgen-Deprivation Therapy Added to Radiation Therapy in Patients With Newly Diagnosed Prostate Cancer

Prospective Study of Homologous Recombination Repair Gene Mutation Prevalence in Patients With Advanced Prostate Cancer From Latin America: Challenges and Future Approaches A model of absolute risk ...